ITeos Therapeutics Inc has a share price target of US$ 24, revenue growth forecast of -78.6%, and profit growth estimate of -29.1% for FY25, based on top 6 analyst calls.
Upgrade Your Plan
You need to upgrade your subscription plan to access this feature